$MRK News Article - European Medicines Agency Adop
Post# of 151
(Total Views: 426)
Posted On: 07/29/2019 1:15:40 PM
$MRK News Article - European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA (pembrolizumab) in Combination with Inlyta (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma https://marketwirenews.com/news-releases/euro...50070.html
(0)
(0)Merck & Co. Inc. (MRK) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼